females of polycystic ovary syndromes may complain fatty pancreaetic disorder and thyroid hypofunctions (subclinical hypothyroidism)
females of polycystic ovary syndromes may complain fatty pancreaetic disorder and thyroid hypofunctions (subclinical hypothyroidism) will be divided to groups (twenty female for the group). groups will be treated with levothyroxine and metformin, but one of these groups will perform aerobic treadmill walking.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
40
twenty females of polycystic ovary syndromes may complain fatty pancreaetic disorder and thyroid hypofunctions (subclinical hypothyroidism)will be treated with daily dose of levothyroxine in addition to daily twotimes of 500-mg metformin, and these females will perform 50 minutes of aerobic treadmill walking hrice weekly for six month.
twenty females of polycystic ovary syndromes may complain fatty pancreaetic disorder and thyroid hypofunctions (subclinical hypothyroidism)will be treated with daily dose of levothyroxine in addition to daily two times of 500-mg metformin for six month.
Cairo Unoversity
Giza, Egypt
RECRUITINGDehydroepiandrosterone
it is a hormone involved in synthesis of sex hormones
Time frame: it will be measured after 6 months
ratio of leutinzing hromone to hormone of follicels stimulatting hormones
this ration express level of sex hormone
Time frame: it will be measured after 6 months
testesterone
it is a sex horomone
Time frame: it will be measured after 6 months
body mass index
it will be assessed on empty stomach and bladder
Time frame: it will be measured after 6 months
waist circumference
it will be assessed on umblical levels
Time frame: it will be measured after 6 months
blood gluocose
it will be assessed in fasting status
Time frame: it will be measured after 6 months
glycated hemoglubin
it is an indiactor for longterm satus of blood gloucose
Time frame: it will be measured after 6 months
insulin
it will be assessed in plasma
Time frame: it will be measured after 6 months
thyroid stimualtined horomone
it will be assessed in plasma
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: it will be measured after 6 months
triglyceridess
it will be assessed in plasma
Time frame: it will be measured after 6 months
low densitiy liopporotein
it will be assessed in plasma
Time frame: it will be measured after 6 months
cholesteroll
it will be assessed in plasma
Time frame: it will be measured after 6 months
high densitiy lipoporteins
it will be assessed in plasma
Time frame: it will be measured after 6 months
alanine transaminase
it will be assessed in plasma
Time frame: it will be measured after 6 months
aspartatte transaminase
it will be assessed in plasma
Time frame: it will be measured after 6 months